Jefferies raises CoreWeave stock price target on major deals By Investing.com

CoreWeave’s outlook was lifted after a string of April AI infrastructure deals, including a $21 billion Meta agreement and a $6 billion Jane Street contract, with remaining performance obligations expected to exceed $95 billion versus $67 billion in Q4. Jefferies raised its price target to $160 from $120 and kept a Buy rating, citing strong demand for AI compute and the company’s position in hosting complex workloads. The article also notes a $1 billion senior notes offering at 9.75% and ongoing concerns around valuation and profitability, including negative EPS of -$2.81.

Analysis

The market is starting to price CRWV less as a pure growth story and more as a financing-and-execution story. The key second-order effect is that the larger the contracted backlog becomes, the more the equity market should care about balance-sheet durability and cost of capital rather than headline demand; that is why the recent debt issuance matters as much as the revenue guide. If management can keep utilization high while avoiding margin leakage, the stock can re-rate on operating leverage, but any evidence of aggressive capex or weaker conversion from bookings to cash flow will quickly compress the multiple.

For META, the implication is not just access to compute but optionality: securing capacity externally reduces near-term constraint risk on AI product rollouts without requiring all incremental demand to be met by in-house buildout. That is mildly supportive for execution, but it also signals that hyperscalers are willing to arbitrage between internal and third-party supply, which limits supplier pricing power over time. The longer-term winner may be the broader AI infrastructure stack, but the first place the market usually takes profits is in the highest-beta beneficiary once backlog becomes consensus.

The contrarian risk is that the current narrative assumes demand permanence while ignoring duration mismatch: multi-year commitments can look like quality until the market re-prices growth assets for higher rates or customer spending normalizes. The most likely reversal catalyst is not a collapse in AI demand but a sequence of smaller misses on utilization, margins, or incremental funding terms over the next 1-3 quarters. In that scenario, CRWV can derate faster than fundamentals deteriorate because the equity is implicitly underwriting both growth and credit confidence at once.

Key Decisions for Investors

• Long CRWV only via call spreads rather than stock: 3-6 month upside participation with defined downside, because the main risk is multiple compression if financing or margin optics deteriorate.
• Pair trade: long META / short CRWV into strength over the next 4-8 weeks; META benefits from optionality and capacity assurance, while CRWV carries the tighter execution and funding risk premium.
• If already long CRWV, hedge with short-dated puts around the next earnings window; the stock is likely to trade on guide quality and cash conversion more than backlog headlines.
• Watch the credit market closely: if CRWV notes trade wider by 100-150 bps after issuance, reduce equity exposure, because the equity thesis is increasingly levered to low-risk refinancing access.